EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Optimizing risk stratification for intermediate-risk prostate cancer – the prognostic value of baseline health-related quality of life

Thilo Westhofen, Alexander Buchner, Simon Lennartz, Severin Rodler, Lennert Eismann, Can Aydogdu, Darjusch Askari-Motlagh, Elena Berg, Enya Feyerabend, Philipp Kazmierczak, Friedrich Jokisch, Armin Becker und 2 weitere

World Journal of Urology · 2024

DOI: 10.1007/s00345-024-05298-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Urology, 2024. Verfasst von Thilo Westhofen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Ludwig-Maximilians-University of Munich, Marchioninistrasse 15, 81377, Munich, Germany. Thilo.westhofen@med.uni-muenchen.de. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Quality of Life, Prostatectomy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Klinikum der Universität München.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To investigate the prognostic value of baseline health-related quality of life (HRQOL) for patients with intermediate-risk localized prostate cancer (IR-PCa) undergoing radical prostatectomy (RP).

Methods

4780 patients with IR-PCa according to NCCN risk stratification were identified from a prospectively maintained database. All patients were treated with RP and had prospectively assessed baseline HRQOL. Main outcomes were oncologic endpoints metastasis-free survival (MFS); biochemical recurrence free survival (BRFS) and overall survival (OS). Multivariable Cox regression models assessed prognostic significance of baseline global health status (GHS) on survival outcomes. Harrell’s discrimination C-index was applied to calculate the predictive accuracy of the model. Decision curve analysis (DCA) tested the clinical net benefit associated with adding the GHS domain to our multivariable model ( p < 0.05).

Results

Median follow-up was 51 months. Multivariable analysis confirmed baseline GHS as an independent predictor for increased MFS (HR 0.976, 95%CI 0.96–0.99; p < 0.001), increased BRFS (HR 0.993, 95%CI 0.99–1.00; p = 0.027) and increased OS (HR 0.969, 95%CI 0.95–0.99; p = 0.002), indicating a relative risk reduction of 2.4% for MFS, 0.7% for BRFS and 3.1% for OS per 1-point increase of baseline GHS. Baseline HRQOL improved discrimination in predicting MFS, BRFS and OS. DCA revealed a net benefit over all threshold probabilities.

Conclusions

We found baseline HRQOL to substantially improve risk stratification for the heterogeneous cohort of IR-PCa. Baseline HRQOL accurately predicts increased MFS, BRFS and OS. Our findings therefore support the role of preoperative HRQOL as an adjunct to established prognosticators for IR-PCa, potentially facilitating guidance of therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsQuality of LifeProstatectomyHumansMalePrognosisRisk AssessmentMiddle AgedAgedProspective StudiesSurvival Rate

Stichwörter der Autor:innen

EORTC QLQ-C30Health-related quality of lifeIntermediate-risk prostate cancerMetastasis-free survivalRadical prostatectomyRisk stratification

Autor:innen und Institutionen

  • Department of Urology, Ludwig-Maximilians-University of Munich, Marchioninistrasse 15, 81377, Munich, Germany. Thilo.westhofen@med.uni-muenchen.de.
  • Department of Urology, Ludwig-Maximilians-University of Munich, Marchioninistrasse 15, 81377, Munich, Germany.
  • Institute for Diagnostic and Interventional Radiology, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.
  • Institute for Diagnostic and Interventional Radiology, Ludwig-Maximilians-University of Munich, Munich, Germany.

Förderung

  • Klinikum der Universität München

Zitieren

APA

Westhofen, T., Buchner, A., Lennartz, S., Rodler, S., Eismann, L., Aydogdu, C., Askari-Motlagh, D., Berg, E., Feyerabend, E., Kazmierczak, P., Jokisch, F., Becker, A., Stief, C. G., & Kretschmer, A. (2024). Optimizing risk stratification for intermediate-risk prostate cancer – the prognostic value of baseline health-related quality of life. World Journal of Urology. https://doi.org/10.1007/s00345-024-05298-2

Vancouver

Westhofen T, Buchner A, Lennartz S, Rodler S, Eismann L, Aydogdu C, et al. Optimizing risk stratification for intermediate-risk prostate cancer – the prognostic value of baseline health-related quality of life. World Journal of Urology. 2024. doi:10.1007/s00345-024-05298-2

BibTeX
@article{Westhofen2024,
  author = {Westhofen, Thilo and Buchner, Alexander and Lennartz, Simon and Rodler, Severin and Eismann, Lennert and Aydogdu, Can and Askari-Motlagh, Darjusch and Berg, Elena and Feyerabend, Enya and Kazmierczak, Philipp and Jokisch, Friedrich and Becker, Armin and Stief, Christian G and Kretschmer, Alexander},
  title = {Optimizing risk stratification for intermediate-risk prostate cancer – the prognostic value of baseline health-related quality of life},
  journal = {World Journal of Urology},
  year = {2024},
  doi = {10.1007/s00345-024-05298-2}
}
Kostenlos starten →